NO863228D0 - Fremgangsmaate for fremstilling av farmakodynamiske aktive benzimidazol-derivater. - Google Patents

Fremgangsmaate for fremstilling av farmakodynamiske aktive benzimidazol-derivater.

Info

Publication number
NO863228D0
NO863228D0 NO863228A NO863228A NO863228D0 NO 863228 D0 NO863228 D0 NO 863228D0 NO 863228 A NO863228 A NO 863228A NO 863228 A NO863228 A NO 863228A NO 863228 D0 NO863228 D0 NO 863228D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
benzimidazole derivatives
active benzimidazole
pharmacodynamic active
Prior art date
Application number
NO863228A
Other languages
English (en)
Other versions
NO863228L (no
Inventor
Albert Fischli
Anna Krasso
Andre Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO863228D0 publication Critical patent/NO863228D0/no
Publication of NO863228L publication Critical patent/NO863228L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36Sulfur atom
    • C07D473/38Sulfur atom attached in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO863228A 1985-08-12 1986-08-11 Fremgangsmaate for fremstilling av farmakodynamisk aktive benzimidazol-derivater. NO863228L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH345585 1985-08-12
CH235086 1986-06-10

Publications (2)

Publication Number Publication Date
NO863228D0 true NO863228D0 (no) 1986-08-11
NO863228L NO863228L (no) 1987-02-13

Family

ID=25690225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863228A NO863228L (no) 1985-08-12 1986-08-11 Fremgangsmaate for fremstilling av farmakodynamisk aktive benzimidazol-derivater.

Country Status (10)

Country Link
US (1) US4766133A (no)
EP (1) EP0214479A3 (no)
AU (1) AU6094386A (no)
DK (1) DK337086A (no)
FI (1) FI863242A7 (no)
HU (1) HUT41766A (no)
IL (1) IL79642A0 (no)
MC (1) MC1771A1 (no)
NO (1) NO863228L (no)
PT (1) PT83188A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0304624A3 (de) * 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
US5162317A (en) * 1988-05-12 1992-11-10 Esai Co., Ltd. Pyridinium salt and pharmacological composition containing the same
US4859679A (en) * 1988-07-19 1989-08-22 Pfizer Inc. Antiulcer (alkyldithio) quinoline derivatives
WO1992009595A1 (de) * 1990-11-29 1992-06-11 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue und bekannte disulfide und ihre verwendung
EP0627920A1 (de) * 1992-02-25 1994-12-14 Byk Gulden Lomberg Chemische Fabrik GmbH Neue und bekannte disulfide und ihre verwendung gegen helicobacter-bakterien
US6323201B1 (en) 1994-12-29 2001-11-27 The Regents Of The University Of California Compounds for inhibition of ceramide-mediated signal transduction
US5894597A (en) * 1996-09-24 1999-04-13 Motorola, Inc. Communication device for different sized cards
DE19745692A1 (de) * 1997-07-24 1999-01-28 Bayer Ag Verfahren zur Herstellung von 2-Chlor-benzimidazol-Derivaten
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
AU2005301608B2 (en) * 2004-11-02 2012-09-13 Msd K.K. Aryloxy-substituted benzimidazole derivatives
GB2447572B (en) * 2005-11-17 2011-06-01 Jon Pty Ltd Pharmacologically active disulfide compounds
EP3668521B1 (en) * 2017-08-14 2024-10-02 The Regents of the University of Colorado, a body corporate Inhibition of oxidative stress, glycation, and protein crosslinking

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993302A (en) * 1963-03-13 1965-05-26 Carter Prod Inc Nitrogen-containing heterocyclic disulfides
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (no) * 1977-09-19 1981-07-25 Hoffmann La Roche
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4302464A (en) * 1980-10-16 1981-11-24 Pfizer Inc. Imidazolylpyridine therapeutic agents
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
SE8405588D0 (sv) * 1984-11-08 1984-11-08 Haessle Ab New compounds

Also Published As

Publication number Publication date
MC1771A1 (fr) 1987-07-17
EP0214479A3 (de) 1987-08-05
DK337086D0 (da) 1986-07-15
HUT41766A (en) 1987-05-28
AU6094386A (en) 1987-02-19
DK337086A (da) 1987-02-13
US4766133A (en) 1988-08-23
PT83188A (en) 1986-09-01
FI863242A7 (fi) 1987-02-13
NO863228L (no) 1987-02-13
FI863242A0 (fi) 1986-08-08
EP0214479A2 (de) 1987-03-18
IL79642A0 (en) 1986-11-30

Similar Documents

Publication Publication Date Title
FI872864L (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
FI874702A7 (fi) Menetelmä uusien bentsimidatsolijohdannaisten valmistamiseksi.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO862661D0 (no) Fremgangsmaate for fremstilling av n-aralkylpiperidinmethanolderivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO862861L (no) Fremgangsmaate for fremstilling av distamycinderivater.
NO864110L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
ES557731A0 (es) Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona
NO863251L (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
FI863242A7 (fi) Benzimidazolderivat.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO862493L (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.